Venous thromboembolism following elective knee arthroscopy remains relatively rare. NuvaRing (Merck & Co), an intravaginal contraceptive device, has received attention recently due to reports detailing unexpected catastrophic pulmonary embolism and further suggesting an increased risk of venous and arterial thrombotic events in women who use it. A healthy, 30-year-old woman with a NuvaRing contraceptive device presented to the sports medicine clinic with knee pain, swelling, and mechanical symptoms. She was diagnosed with a lateral meniscus tear via magnetic resonance imaging and subsequently underwent a routine partial lateral meniscectomy. Her postoperative course was complicated by a rare deep venous thrombosis requiring anticoagulation therapy. This case highlights the risk of NuvaRing contraception and raises awareness within the orthopedic community regarding its use among patients undergoing arthroscopic outpatient surgery. [Orthopedics. 2021;44(5):e687-e690.].